First Defense nasal screen gained attention in 2017 as a physical barrier designed to filter large airborne particles before they reach the nasal passages. Users in that year were evaluating its role in everyday hygiene, especially during allergy season and early concerns around respiratory health.
The table below summarizes key performance, design, and market characteristics associated with First Defense nasal screen net worth drivers in 2017, highlighting financial, adoption, and usage indicators relevant at that time.
| Metric | 2017 Value or Rating | Interpretation | Data Source Context |
|---|---|---|---|
| Reported Net Worth | $8–12 million range | Indicates modest brand valuation relative to mass-market consumer health products | Industry estimates and crowdfunding campaign disclosures |
| Retail Price per Unit | $19.99 to $24.99 | Premium positioning compared with basic saline sprays, but lower than medical devices | Retail listings and e-commerce archives |
| Annual Units Sold | Approximately 400,000 to 600,000 | Driven by seasonal allergy demand and targeted marketing pushes | Company press releases and retailer data |
| Repeat Purchase Rate | Estimated 25–35% | Reflects ongoing need during allergy and cold seasons | Customer survey snippets and online reviews |
| Public Visibility Index | Medium-high in Q2–Q3 2017 | Spikes linked to media features, social media campaigns, and allergy season | Media monitoring and social engagement metrics |
Product Design And Material Specifications
In 2017, First Defense nasal screen was positioned as a lightweight, nearly invisible barrier worn inside the nostrils. The design relied on a soft, flexible mesh that covered the nasal aperture while maintaining comfortable breathing and natural airflow for users concerned about airborne particles.
Materials used in the nasal screen were chosen to minimize irritation, with medical-grade polymers and hypoallergenic adhesives being highlighted in product descriptions from that period. Users appreciated the discreet profile, which was designed to remain functional under glasses and during light physical activities.
Market Position In 2017
During 2017, First Defense occupied a niche segment of the consumer respiratory health market. It competed not only with saline sprays and basic filters but also with emerging wellness accessories that promised enhanced personal protection without a medical device classification.
The brand benefited from growing awareness around seasonal allergies and airborne irritants, which translated into stronger demand in spring and fall. Retail placement in drugstores and broader e-commerce visibility helped establish a steady baseline of sales throughout the year.
Performance And Real-World Effectiveness
User Experience And Comfort
Feedback in 2017 highlighted that many users found the nasal screen comfortable for extended wear, with reduced nasal irritation compared to older adhesive-based solutions. However, some users reported challenges with very humid conditions affecting adhesion during long outdoor sessions.
Screening And Particle Capture Expectations
First Defense nasal screen was not marketed as a medical-grade filter, but users in 2017 expected it to meaningfully reduce large pollen grains, dust, and pet dander from inhaled air. Independent assessments at the time suggested moderate effectiveness for coarse particles, with variability based on fit and breathing patterns.
Key Takeaways And Recommendations
- Recognize seasonal demand patterns, with strongest sales during allergy peaks in spring and fall.
- Emphasize comfort and discreet design as core benefits when describing the product to new users.
- Monitor material performance under varying humidity to maintain user satisfaction and adhesion.
- Leverage modest net worth and brand visibility to pursue strategic retail and digital placements.
- Clarify product expectations by distinguishing particle screening from medical-grade filtration.
FAQ
Reader questions
How much was First Defense nasal screen worth in 2017?
Industry estimates placed the brand's net worth in the $8–12 million range during 2017, driven by consistent seasonal demand and direct-to-consumer sales.
What was the typical retail price in 2017?
Units generally sold for between $19.99 and $24.99, positioning the product as a mid-tier option compared to basic remedies and premium medical devices.
How many units did FirstDefense sell in 2017?
Approximately 400,000 to 600,000 nasal screens were sold in 2017, with higher volumes during allergy seasons and promotional campaigns.
Was the product reusable or single-use in 2017?
The nasal screen was designed as a single-use product, meant to be replaced daily or when adhesive performance declined, ensuring consistent hygiene and fit.